Show simple item record

dc.contributor.authorNgugi, P M
dc.date.accessioned2013-04-29T15:02:46Z
dc.date.available2013-04-29T15:02:46Z
dc.date.issued2007-09
dc.identifier.citationEast Africa Medical Journal. 2007sep;84(9 suppl):S36-9en
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/pubmed/18154201
dc.identifier.urihttp://erepository.uonbi.ac.ke:8080/xmlui/handle/123456789/17844
dc.description.abstractOBJECTIVE: To obtain an update of the treatment of advanced prostate cancer. DATA SOURCE: Review of all published literature on advanced prostate cancer was carried out through medline and index medicus search. DATA SELECTION: Published data on advanced prostate cancer from June 2005 to June 2007 was included in the review. DATA EXTRACTION: Abstracts of articles identified were assessed, read and analysed to determine relevance to the title under review. DATA SYNTHESIS: After establishing relevance from the abstract, the entire paper was read, and significant points included in the review. CONCLUSION: The mainstay of treatment of advanced prostate cancer remains hormone withdrawal. The introduction of docetaxel based chemotherapy has caused a paradigm shift.en
dc.language.isoenen
dc.subjectTreatmenten
dc.subjectAdvanced Prostrate canceren
dc.titleAn update on the treatment of advanced prostate canceren
dc.typeArticleen
local.publisherDepartment of Surgery, University of Nairobien


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record